Julio Licinio-Gives the right direction to become expert in the psychiatry field
Posted by JulioLicinio on November 15th, 2018
Psychiatry is one of the most famous courses taken by undergrads. It gives many benefits when you graduate with a qualification. You can be a Doctor of Medicine where you can treat people with mental disabilities or mental difficulties. You can also work for the human connections department of huge companies. There are many colleges and universities give these courses in the common subjects given normally to learners and student students. The courses offered to these students do not search deeper into the important subjects in individual psychiatry courses.
This subject tackled only the methodologies of medicine, especially those prepared in Experimental psychiatry course, where the entire lessons are very helpful in educational research done by different courses. There is one famous man called Julio Licinio who is master in the psychiatry field, give some really promising career opportunities that are observed to last collapses and meltdowns. Dr. Julio Licinio is a retired assistant professor of Psychiatry at Yale. He has been given the position of senior Vice president and dignitary of the College of Medicine at Upstate Medical University in Syracuse, New York.
About his education, Julio Licinio lived in the United States for like 25 years, but he earned his MD degree in the year 1982 from the Federal University of Bahia. He has completed his residency at the University of Sao Paulo in internal medicine. Julio Licinio moved to the United States to finish his training in endocrinology at the University of Chicago and psychiatry at the Albert Einstein. He has listed himself as a professional in psychiatry by the Australian Health Practitioner Regulation Agency.
Julio Licinio earns a good reputation and followed by many people who actually love them, His expertise field is pharmacogenomics and biology of depression and so he has written the books on these topics. He has observed the relationship between obesity and anti-depressant.